Award
National Institute of Allergy and Infectious Diseases 5R01AI170298-04
A platform for monitoring the efficacy and optimal dosing of long-acting ART
Recipient
University of Colorado Denver
Award Amount
$630,573.00
Ceiling
$630,573.00
Awarded
July 16, 2025
Identifier
5R01AI170298-04
NIH-funded project to develop a platform for monitoring long-acting ART efficacy and dosing, involving University of Colorado Denver, focusing on personalized HIV treatment.
Description
The project aims to develop and validate at-home self-collections and point-of-care testing for long-acting HIV therapies, supporting personalized treatment strategies. The project emphasizes innovation in pharmacokinetic monitoring and aims to improve patient management in real-world settings.